Nappi, Mario Gain of Function Effect Caused by Inner Pore Variants in Kv7.2, Kv7.3 and Kv7.5 Potassium Channels Identified in Patients with Developmental and/or Epileptic Encephalopathy. [Tesi di dottorato]

[thumbnail of Nappi_Mario_36.pdf]
Anteprima
Testo
Nappi_Mario_36.pdf

Download (7MB) | Anteprima
Tipologia del documento: Tesi di dottorato
Lingua: English
Titolo: Gain of Function Effect Caused by Inner Pore Variants in Kv7.2, Kv7.3 and Kv7.5 Potassium Channels Identified in Patients with Developmental and/or Epileptic Encephalopathy
Autori:
Autore
Email
Nappi, Mario
mario.nappi@unina.it
Numero di pagine: 133
Istituzione: Università degli Studi di Napoli Federico II
Dipartimento: Neuroscienze e Scienze Riproduttive ed Odontostomatologichei
Dottorato: Neuroscienze
Ciclo di dottorato: 36
Coordinatore del Corso di dottorato:
nome
email
Taglialatela, Maurizio
mtaglial@unina.it
Tutor:
nome
email
Taglialatela, Maurizio
[non definito]
Numero di pagine: 133
Parole chiave: Potassium channels; Epilepsy
Settori scientifico-disciplinari del MIUR: Area 05 - Scienze biologiche > BIO/14 - Farmacologia
Depositato il: 18 Mar 2024 09:34
Ultima modifica: 04 Mag 2026 07:39
URI: http://www.fedoa.unina.it/id/eprint/15727

Abstract

Developmental and epileptic encephalopathies (DEE) are a heterogeneous group of rare neurodevelopmental disorders, characterised by seizures, electroencephalographic abnormalities or developmental delay or regression. DEEs have often a genetic etiology and KCNQ are among the most frequently affected genes. these encodes for a family of voltage gated potassium channel subunit and consists of five members (KCNQ1-5). In the present work, we describe the clinical and in vitro functional features of six patients each carrying a heterozygous de novo mutation in KCNQ2, KCNQ3 or KCNQ5, responsible for introducing substitutions in the activation gate of the pore region. We characterise the biophysical properties of these variants and classify them as gain- or loss-of-function variants. We also describe the structural alterations that these mutations induce through molecular dynamics. Finally, we tested 10 micromolar amitriptyline to evaluate the ability of the compound to reverse the in vitro phenotype, showing that this drug is able to reverse the current density of channels. Functional characterisations of de novo variants are crucial to understand pathogenesis of DEEs, to guide therapy and to implement personalised treatments.

Downloads

Downloads per month over past year

Actions (login required)

Modifica documento Modifica documento